Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3359441
Max Phase: Preclinical
Molecular Formula: C38H58O12
Molecular Weight: 706.87
Molecule Type: Small molecule
Associated Items:
ID: ALA3359441
Max Phase: Preclinical
Molecular Formula: C38H58O12
Molecular Weight: 706.87
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)O[C@@H]1C[C@@]23C[C@@]24CC[C@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)C(C)(C)[C@@H]4CC[C@H]3[C@]2(C)C[C@]3(O)O[C@H](C(=O)[C@@H]4OC4(C)C)[C@@H](C)[C@@H]3[C@@]12C
Standard InChI: InChI=1S/C38H58O12/c1-17-28(27(44)30-33(5,6)50-30)49-38(45)15-34(7)21-10-9-20-32(3,4)22(48-31-26(43)25(42)24(41)19(14-39)47-31)11-12-36(20)16-37(21,36)13-23(46-18(2)40)35(34,8)29(17)38/h17,19-26,28-31,39,41-43,45H,9-16H2,1-8H3/t17-,19-,20+,21+,22+,23-,24+,25+,26-,28+,29-,30+,31+,34+,35-,36-,37+,38+/m1/s1
Standard InChI Key: BBCOSGGRXMFJEE-NZGURJJWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 706.87 | Molecular Weight (Monoisotopic): 706.3928 | AlogP: 2.23 | #Rotatable Bonds: 6 |
Polar Surface Area: 184.74 | Molecular Species: NEUTRAL | HBA: 12 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.64 | CX Basic pKa: | CX LogP: 1.87 | CX LogD: 1.87 |
Aromatic Rings: 0 | Heavy Atoms: 50 | QED Weighted: 0.15 | Np Likeness Score: 2.71 |
1. Su Y, Wu L, Wang Q, Yang B, Kuang H.. (2014) New 9,19-cycloartenol glycosides isolated from the roots of Cimicifuga simplex and their anti-inflammatory effects., 24 (24): [PMID:25467162] [10.1016/j.bmcl.2014.10.066] |
2. Su Y, Wu L, Mu G, Wang Q, Yang B, Cheng G, Kuang H.. (2017) 9,19-Cycloartenol glycoside G3 from Cimicifuga simplex regulates immune responses by modulating Th17/Treg ratio., 25 (17): [PMID:28780985] [10.1016/j.bmc.2017.07.042] |
Source(1):